JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265465

Human ANKRD17 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ANKRD17 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

ANR17_HUMAN, Ankyrin repeat domain protein 17, Ankyrin repeat domain-containing protein 17, FLJ22206, GTAR, Gene trap ankyrin repeat, Gene trap ankyrin repeat protein, KIAA0697, MASK2, NY-BR-16, Serologically defined breast cancer antigen NY-BR-16

1 Images
Sanger Sequencing - Human ANKRD17 knockout HeLa cell line (AB265465)
  • Sanger seq

Unknown

Sanger Sequencing - Human ANKRD17 knockout HeLa cell line (AB265465)

Homozygous : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265465-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265465 Human ANKRD17 knockout HeLa cell line", "number":"AB265465-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265465-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265465 Human ANKRD17 knockout HeLa cell line", "number":"AB265465-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ANKRD17
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ANKRD17 also known as Ankyrin Repeat Domain-containing protein 17 performs key mechanical roles within the cell. This protein weighs around 260 kDa. ANKRD17 is found throughout the human body with notable expression in the brain and liver. It functions importantly in the regulation of cell cycle and nucleocytoplasmic transport through its ankyrin repeat domains which allow interactions with other proteins.
Biological function summary

ANKRD17 engages in processes such as gene expression regulation and immune response. It is a member of protein complexes involved in these pathways. ANKRD17 modulates the transcriptional activity of certain genes and plays a part in antiviral response due to its role in signaling pathways that detect viral infections. These roles reflect its significance in maintaining cellular homeostasis.

Pathways

ANKRD17 participates mainly in the NF-κB and p53 signaling pathways. In the NF-κB pathway ANKRD17 interacts with proteins like IκB facilitating processes that control inflammation and immune responses. In the p53 pathway it associates with the p53 protein regulating cell cycle arrest and apoptosis. Its involvement in these pathways highlights its function in monitoring cell integrity and response to stress or damage.

ANKRD17 has associations with hepatocellular carcinoma and viral infections. It interacts with tumor suppressor proteins like p53 where its altered function can contribute to cancer development by affecting cell cycle control and apoptosis. In viral infections such as influenza ANKRD17's role in immune signaling can impact the body's ability to effectively respond to pathogens. Understanding these connections emphasizes its potential as a therapeutic target.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com